Could this problem? if it really is a botched trial potentially be repeated in our other clinical trials currently running? My guess would be all trials undertaken before the new supply deal would have come from the same incompetent manufacturers?
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-331
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $617.9M |
Open | High | Low | Value | Volume |
32.5¢ | 34.3¢ | 32.5¢ | $1.814M | 5.424M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 489055 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 340303 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 456250 | 0.335 |
1 | 15044 | 0.330 |
6 | 488242 | 0.325 |
13 | 722149 | 0.320 |
10 | 469099 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 310000 | 3 |
0.350 | 303272 | 7 |
0.355 | 264833 | 2 |
0.360 | 157708 | 4 |
0.365 | 259695 | 6 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online